Targeted therapy: ARIEL3 - broad benefit of PARP inhibitors in ovarian cancer
Nat Rev Clin Oncol
.
2017 Dec;14(12):713.
doi: 10.1038/nrclinonc.2017.161.
Epub 2017 Oct 10.
Author
David Killock
PMID:
28994419
DOI:
10.1038/nrclinonc.2017.161
No abstract available